SERO Group is excited to announce the arrival of Christopher Corso, MD, PhD. Dr. Corso received his PhD in Bioengineering at Georgia Institute of Technology before attending Emory University School of Medicine, graduating in 2012.
Dr. Corso recently completed his radiation oncology residency at Yale University School of Medicine where he served as chief resident. He has a special interest in the use of stereotactic body radiation therapy (SBRT) for a variety of malignancies. Outside of the office, he enjoys camping, exercise and spending time with his wife and two children.
Dr. Corso started seeing patients on July 10, 2017 and will be practicing at various SERO departments.
Welcome, Dr. Corso!